BR9607225A - Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanos - Google Patents
Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanosInfo
- Publication number
- BR9607225A BR9607225A BR9607225A BR9607225A BR9607225A BR 9607225 A BR9607225 A BR 9607225A BR 9607225 A BR9607225 A BR 9607225A BR 9607225 A BR9607225 A BR 9607225A BR 9607225 A BR9607225 A BR 9607225A
- Authority
- BR
- Brazil
- Prior art keywords
- restenosis
- prophylaxis
- treatment
- pharmaceutical preparation
- including humans
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 208000037803 restenosis Diseases 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9500897A SE9500897D0 (sv) | 1995-03-14 | 1995-03-14 | The pharmacological use of certain cystine derivatives |
PCT/SE1996/000320 WO1996028149A1 (en) | 1995-03-14 | 1996-03-12 | The pharmacological use of certain cystine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607225A true BR9607225A (pt) | 1998-07-07 |
Family
ID=20397536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607225A BR9607225A (pt) | 1995-03-14 | 1996-03-12 | Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanos |
Country Status (24)
Country | Link |
---|---|
US (1) | US5883126A (pt) |
EP (1) | EP0814798A1 (pt) |
JP (1) | JPH11501916A (pt) |
KR (1) | KR19980703055A (pt) |
CN (1) | CN1183718A (pt) |
AR (1) | AR002716A1 (pt) |
AU (1) | AU701287B2 (pt) |
BR (1) | BR9607225A (pt) |
CA (1) | CA2214831A1 (pt) |
CZ (1) | CZ288219B6 (pt) |
EE (1) | EE03382B1 (pt) |
HU (1) | HUP9801985A3 (pt) |
IL (1) | IL117465A (pt) |
IS (1) | IS4554A (pt) |
NO (1) | NO974143L (pt) |
NZ (1) | NZ303781A (pt) |
PL (1) | PL183234B1 (pt) |
SE (1) | SE9500897D0 (pt) |
SK (1) | SK282448B6 (pt) |
TR (1) | TR199700945T1 (pt) |
TW (1) | TW385249B (pt) |
UA (1) | UA42830C2 (pt) |
WO (1) | WO1996028149A1 (pt) |
ZA (1) | ZA961749B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6007819A (en) * | 1995-10-17 | 1999-12-28 | Dovetail Technologies, Inc. | Methods of inducing immunity using low molecular weight immune stimulants |
DE19821625C1 (de) * | 1998-05-15 | 2000-01-05 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
SE9900438D0 (sv) * | 1999-02-10 | 1999-02-10 | Astra Ab | The pharmacological use of certian cystine derivatives |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR8205M (pt) * | 1968-12-20 | 1970-09-14 | ||
US3878305A (en) * | 1972-05-25 | 1975-04-15 | Procter & Gamble | Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids |
FR2289179A1 (fr) * | 1974-10-28 | 1976-05-28 | Morelle Jean | Sels metalliques de lipoaminoacides |
US3952115A (en) * | 1975-04-02 | 1976-04-20 | The Procter & Gamble Company | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters |
GB2097256B (en) * | 1981-04-02 | 1985-05-30 | Morelle Jean V | Compositions containing n-butyryl alphaaminoacids |
FR2503151A1 (fr) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux |
US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
US4708965A (en) * | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
US4827016A (en) * | 1985-09-16 | 1989-05-02 | Morgan Lee R | Method and compounds for reducing dermal inflammations |
JPS62195356A (ja) * | 1986-02-20 | 1987-08-28 | Seiwa Kasei:Kk | シスチン誘導体及びその塩 |
IL98310A (en) * | 1990-06-08 | 1996-08-04 | Astra Ab | Medicinal preparations containing a history of cystine |
TW221376B (pt) * | 1990-06-28 | 1994-03-01 | Astra Ab | |
IT1249650B (it) * | 1991-05-29 | 1995-03-09 | Poli Ind Chimica Spa | N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico |
SE9103572D0 (sv) * | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
WO1993013660A1 (en) * | 1992-01-06 | 1993-07-22 | Health Maintenance Programs, Inc. | Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
DE4224670A1 (de) * | 1992-07-25 | 1994-01-27 | Boehringer Mannheim Gmbh | Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker |
-
1995
- 1995-03-14 SE SE9500897A patent/SE9500897D0/xx unknown
-
1996
- 1996-02-16 TW TW085101975A patent/TW385249B/zh not_active IP Right Cessation
- 1996-03-04 ZA ZA961749A patent/ZA961749B/xx unknown
- 1996-03-12 EP EP96906992A patent/EP0814798A1/en not_active Withdrawn
- 1996-03-12 US US08/619,681 patent/US5883126A/en not_active Expired - Fee Related
- 1996-03-12 TR TR97/00945T patent/TR199700945T1/xx unknown
- 1996-03-12 AU AU50185/96A patent/AU701287B2/en not_active Ceased
- 1996-03-12 CA CA002214831A patent/CA2214831A1/en not_active Abandoned
- 1996-03-12 UA UA97105046A patent/UA42830C2/uk unknown
- 1996-03-12 WO PCT/SE1996/000320 patent/WO1996028149A1/en not_active Application Discontinuation
- 1996-03-12 CZ CZ19972804A patent/CZ288219B6/cs not_active IP Right Cessation
- 1996-03-12 KR KR1019970706464A patent/KR19980703055A/ko not_active Application Discontinuation
- 1996-03-12 BR BR9607225A patent/BR9607225A/pt not_active Application Discontinuation
- 1996-03-12 CN CN96193717A patent/CN1183718A/zh active Pending
- 1996-03-12 EE EE9700229A patent/EE03382B1/xx not_active IP Right Cessation
- 1996-03-12 JP JP8527519A patent/JPH11501916A/ja active Pending
- 1996-03-12 HU HU9801985A patent/HUP9801985A3/hu unknown
- 1996-03-12 SK SK1207-97A patent/SK282448B6/sk unknown
- 1996-03-13 AR ARP960101738A patent/AR002716A1/es unknown
- 1996-03-13 IL IL11746596A patent/IL117465A/xx not_active IP Right Cessation
- 1996-03-29 NZ NZ303781A patent/NZ303781A/en unknown
- 1996-03-29 PL PL96322328A patent/PL183234B1/pl unknown
-
1997
- 1997-08-27 IS IS4554A patent/IS4554A/is unknown
- 1997-09-09 NO NO974143A patent/NO974143L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE03382B1 (et) | 2001-04-16 |
IS4554A (is) | 1997-08-27 |
NO974143D0 (no) | 1997-09-09 |
WO1996028149A1 (en) | 1996-09-19 |
IL117465A0 (en) | 1996-07-23 |
SK120797A3 (en) | 1998-02-04 |
CN1183718A (zh) | 1998-06-03 |
PL322328A1 (en) | 1998-01-19 |
CZ280497A3 (cs) | 1998-01-14 |
JPH11501916A (ja) | 1999-02-16 |
KR19980703055A (ko) | 1998-09-05 |
TW385249B (en) | 2000-03-21 |
MX9706825A (es) | 1997-11-29 |
NZ303781A (en) | 2001-03-30 |
AU5018596A (en) | 1996-10-02 |
SE9500897D0 (sv) | 1995-03-14 |
UA42830C2 (uk) | 2001-11-15 |
SK282448B6 (sk) | 2002-02-05 |
CZ288219B6 (en) | 2001-05-16 |
EE9700229A (et) | 1998-04-15 |
IL117465A (en) | 2000-07-26 |
TR199700945T1 (xx) | 1998-02-21 |
PL183234B1 (pl) | 2002-06-28 |
US5883126A (en) | 1999-03-16 |
EP0814798A1 (en) | 1998-01-07 |
AR002716A1 (es) | 1998-04-29 |
CA2214831A1 (en) | 1996-09-19 |
NO974143L (no) | 1997-09-09 |
ZA961749B (en) | 1996-09-16 |
HUP9801985A2 (hu) | 1998-12-28 |
HUP9801985A3 (en) | 2000-07-28 |
AU701287B2 (en) | 1999-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
BR9605111A (pt) | Formulação de dosagem farmacêutica oral processo para a manufatura de uma formulação de dosagem fixa método para o tratamento de distúrbios com infecções por helicobacter pylori em mamiferos e no ser humano e uso de uma formulação de dosagem | |
BR9306067A (pt) | Processos para proporcionar efeito analgésico e para o tratamento ou prevenção de pirexia em seres humanos e composiç o anagésica e antipirética para o tratamento de seres humanos | |
BR9703624A (pt) | Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem | |
BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
BR9609532A (pt) | Composição antimicrobiana para o tratamento de cabelo processo para o tratamento de caspa e uso da composição | |
BR9407869A (pt) | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose | |
BR9610988A (pt) | Composto uso do mesmo fomulação farmacêutica e processo para produção do composto | |
BR9706968A (pt) | Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x | |
BR9101203A (pt) | Artigo para tratamento de superficie e processo para sua fabricacao | |
BR9708093A (pt) | Composto formulação uso composto e processo para tratamento de distúrbios mediados por 5-hidroxitriptamina e para preparação do composto | |
BR9100046A (pt) | Derivados de azaoxindole,composicao farmaceutica e processo para o tratamento de mamiferos | |
BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
PT779066E (pt) | Artigo absorvente de liquidos em musgo esfagno e metodo para fabricar o artigo absorvente | |
BR9609695A (pt) | Composição herbicida sinérgica e processo para seu uso | |
BR9612283A (pt) | Composição para o tratamento de manchas em peças de roupa e métodos de tratamento | |
BR9702238A (pt) | Uso de um composto composto para uso no tratamento ou prenvenção de uma doença ou patologia envolvendo a produção de citocinas formulação farmacêutica processos de identificaç o de um composto de preparação de um composto e de tratamento ou prevenção de uma doença ou patologia envolvendo uma citocina e composto ou ligando para uso no processo de identificação | |
BR9602337A (pt) | Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento | |
BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
BR9200218A (pt) | Aparelho e processo para o processamento de fibra animal,particurlamente la crua | |
PT915662E (pt) | Produtos revestidos com acucar e processo para a preparacao dos mesmos | |
BR9608407A (pt) | Uso de um composto preparação farmacéutica para uso na profilaxa e/ou tratamento de insuficiência de orgãos múltiplos sistemas e processo para profilaxia e tratamento de insuficiência de órgãos de múltiplos sistemas em mamíferos incluindo homem | |
PT90524A (pt) | Processo e dispositivo para o registo de artigos | |
BR9607225A (pt) | Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanos | |
BR9612206A (pt) | Composto uso do composto composição farmacêutica processo para preparação do composto e para o tratamento da dor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |